千红制药：2025年半年度归属于上市公司股东的净利润同比增长41.17%

Core Insights - The company reported a revenue of 861,771,495.13 yuan for the first half of 2025, reflecting a year-on-year growth of 0.72% [1] - The net profit attributable to shareholders reached 258,050,517.71 yuan, showing a significant year-on-year increase of 41.17% [1]